SCHEMBL86950

SCHEMBL86950

Cc1cccc(CCCOc2ccc(CCC(C)(N)CO)cc2C(F)(F)F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 7/20 0.57
PPARG P37231 2/20 0.37
PPARD Q03181 2/20 0.37
PPARA Q07869 2/20 0.37
NR3C1 P04150 2/20 0.37
S1PR4 O95977 2/20 0.36
S1PR5 Q9H228 2/20 0.36
FFAR4 Q5NUL3 1/20 0.36
S1PR3 Q99500 1/20 0.35
GRM2 Q14416 1/20 0.35
GRM3 Q14832 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
MRGPRX4 Q96LA9 2/20 0.33
FDPS P14324 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL79552 0.99 S1PR1 (0.56) S1PR1PPARGPPARDPPARANR3C1
SCHEMBL79312 0.91 S1PR1 (0.70) S1PR1PPARGPPARDPPARAS1PR4
Hydrochloric Acid SCHEMBL81848 0.90 S1PR1 (0.69) S1PR1PPARGPPARDPPARAS1PR4
SCHEMBL86646 0.88 S1PR1 (0.63) S1PR1PPARGPPARDPPARAS1PR4
SCHEMBL86643 0.88 S1PR1 (0.66) S1PR1S1PR4S1PR5S1PR3
SCHEMBL86791 0.87 S1PR1 (0.54) S1PR1PPARGPPARDPPARAS1PR4
SCHEMBL86516 0.87 S1PR1 (0.62) S1PR1S1PR4S1PR5FFAR4S1PR3
Hydrochloric Acid SCHEMBL81284 0.87 S1PR1 (0.65) S1PR1S1PR4S1PR5S1PR3
Hydrochloric Acid SCHEMBL80879 0.87 S1PR1 (0.62) S1PR1PPARGPPARDPPARAS1PR4
Hydrochloric Acid SCHEMBL79495 0.86 S1PR1 (0.53) S1PR1PPARGPPARDPPARAS1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF HLA-B, HLA-A, HLA-C S1PR1 511/4885PPARG 1030/4885PPARD 1369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.